Suppr超能文献

酮合酶同源物使用丙二酰基单位在 Cervimycin 生物合成中形成酯。

A ketosynthase homolog uses malonyl units to form esters in cervimycin biosynthesis.

机构信息

Leibniz Institute for Natural Product Research and Infection Biology, Jena, Germany.

出版信息

Nat Chem Biol. 2011 Dec 18;8(2):154-61. doi: 10.1038/nchembio.746.

Abstract

Ketosynthases produce the carbon backbones of a vast number of biologically active polyketides by catalyzing Claisen condensations of activated acyl and malonyl building blocks. Here we report that a ketosynthase homolog from Streptomyces tendae, CerJ, unexpectedly forms malonyl esters during the biosynthesis of cervimycin, a glycoside antibiotic against methicillin-resistant Staphylococcus aureus (MRSA). Deletion of cerJ yielded a substantially more active cervimycin variant lacking the malonyl side chain, and in vitro biotransformations revealed that CerJ is capable of transferring malonyl, methylmalonyl and dimethylmalonyl units onto the glycoside. According to phylogenetic analyses and elucidation of the crystal structure, CerJ is functionally and structurally positioned between the ketosynthase catalyzing Claisen condensations and acyl-ACP shuttles, and it features a noncanonical catalytic triad. Site-directed mutagenesis and structures of CerJ in complex with substrates not only allowed us to establish a model for the reaction mechanism but also provided insights into the evolution of this important subclass of the thiolase superfamily.

摘要

酮合酶通过催化活化酰基和丙二酰基构建块的 Claisen 缩合反应,产生大量具有生物活性的聚酮化合物的碳骨架。在这里,我们报道了来自绛红链霉菌的酮合酶同源物 CerJ,在抗耐甲氧西林金黄色葡萄球菌(MRSA)的糖甙抗生素 Cervimycin 的生物合成过程中,出乎意料地形成丙二酰酯。删除 cerJ 产生了一种活性显著提高的 Cervimycin 变体,缺乏丙二酰侧链,体外生物转化表明 CerJ 能够将丙二酰基、甲基丙二酰基和二甲基丙二酰基单元转移到糖基上。根据系统发育分析和晶体结构阐明,CerJ 在功能和结构上位于催化 Claisen 缩合反应的酮合酶和酰基-ACP 穿梭之间,并且具有非典型的催化三联体。定点突变和 CerJ 与底物复合物的结构不仅使我们能够建立反应机制模型,还深入了解了这个硫醇酶超家族的重要亚类的进化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验